Zobrazeno 1 - 10
of 70
pro vyhledávání: '"V. M. Kabanov"'
Autor:
Janusz Lipkowski, V. M. Kabanov, Tatyana A. Kabanova, Pavel G. Polishchuk, Tetiana M. Khristova, Victor E. Kuz’min, Georgiy V. Samoylenko, Sergei A. Andronati, Marina S. Fonari, A. A. Krysko, Victor Ch. Kravtsov, Alexandre Varnek, Olga L. Krysko
Publikováno v:
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, Elsevier, 2013, 21 (15), pp.4646-4661. ⟨10.1016/j.bmc.2013.05.019⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2013, 21 (15), pp.4646-4661. ⟨10.1016/j.bmc.2013.05.019⟩
A series of novel RGD mimetics containing phthalimidine fragment was designed and synthesized. Their antiaggregative activity determined by Born’s method was shown to be due to inhibition of fibrinogen binding to αIIbβ3. Molecular docking of RGD
Autor:
Victor Ch. Kravtsov, A. A. Krysko, Georgiy V. Samoylenko, Alexander Yu. Kornylov, Pavel G. Polishchuk, Olga L. Krysko, Barbara Wicher, V. M. Kabanov, Tatyana A. Kabanova, Sergei A. Andronati
Publikováno v:
Bioorganicmedicinal chemistry letters. 26(7)
A series of 2-piperazin-1-yl-quinazolines were synthesized and evaluated for their antiaggregative activity. The synthesized small molecule compounds have potently inhibited platelet aggregation in vitro and blocked FITC-Fg binding to αIIbβ3 integr
Autor:
Tatyana A. Kabanova, Tetiana M. Khristova, Georgiy V. Samoylenko, Olga L. Krysko, Sergei A. Andronati, Alexandre Varnek, V. M. Kabanov, Victor E. Kuz’min, Alexander Yu. Kornylov, Thierry Langer, Olga Klimchuk, Pavel G. Polishchuk, A. A. Krysko
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (19), pp.7681-7694. ⟨10.1021/acs.jmedchem.5b00865⟩
Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (19), pp.7681-7694. ⟨10.1021/acs.jmedchem.5b00865⟩
This article describes design, virtual screening, synthesis, and biological tests of novel αIIbβ3 antagonists, which inhibit platelet aggregation. Two types of αIIbβ3 antagonists were developed: those binding either closed or open form of the pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7dc92a9416499df300b22ea976f3b15
https://hal.archives-ouvertes.fr/hal-03150648
https://hal.archives-ouvertes.fr/hal-03150648
Autor:
T. L. Karaseva, Tatyana A. Kabanova, D. I. Yatsyuk, V. M. Kabanov, A. A. Krysko, Sergei A. Andronati
Publikováno v:
Pharmaceutical Chemistry Journal. 37:145-148
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 20:4444-4446
The novel RGDF mimetics were synthesized with the use of 4-(1,2,3,4-tetrahydroisoquinoline-7-yl)amino-4-oxobutyric or 5-(1,2,3,4-tetrahydroisoquinoline-7-yl)amino-5-oxopentanoic acids as a surrogate of Arg-Gly motif. The synthesized compounds have de
Autor:
Tatyana A. Kabanova, V. M. Kabanov, Alexandre Varnek, Tetiana M. Khristova, Ruslan Ya. Grygorash, Victor E. Kuz’min, A. A. Krysko, Georgiy V. Samoylenko, Pavel G. Polishchuk, Sergei A. Andronati, Olga L. Krysko
Publikováno v:
Bioorganic & Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters, 2011, 21 (19), pp.5971-5974. ⟨10.1016/j.bmcl.2011.07.063⟩
Bioorganic & Medicinal Chemistry Letters, 2011, 21 (19), pp.5971-5974. ⟨10.1016/j.bmcl.2011.07.063⟩
The novel RGD mimetics with phthalimidine central fragment were synthesized with the use of 4-piperidine-4-yl-butyric, 4-piperidine-4-yl-benzoic, 4-piperazine-4-yl-benzoic and 1,2,3,4-tetrahydroisoquinoline-7-carboxylic acids as surrogates of Arg mot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3a1e46969a2eb3a39ceb63c9593ed0
https://hal.archives-ouvertes.fr/hal-03143717
https://hal.archives-ouvertes.fr/hal-03143717
Autor:
V. M. Kabanov, M. G. Rokachinskaya, N. Ya. Golovenko, Sergei A. Andronati, Mazurov Anatoly A, V. G. Zin'kovskii
Publikováno v:
Pharmaceutical Chemistry Journal. 26:803-807
Publikováno v:
ChemInform. 29
ChemInform Abstract: Synthesis and Properties of Peptidomimetics: Inhibitors of Platelet Aggregation
Publikováno v:
ChemInform. 32
The literature data on effective approaches to the development of the novel peptidomimetics, antagonists of fibrinogen GP IIb/IIIa receptors as potential antithrombotic agents are generalized and systematized in the review. The data obtained by the a
Publikováno v:
Pharmaceutical Chemistry Journal. 26:753-756